Hugel Aesthetics is a division of Hugel Inc., a global leader in the medical aesthetics industry, with headquarters in Newport Beach, California, and offices in Australia and Canada. Our mission is to improve access to aesthetic solutions by developing and successfully commercializing a synergistic aesthetic portfolio that includes botulinum toxin(s), dermal fillers, and additional innovative aesthetic solutions in the United States, Canada, Australia, and New Zealand. Our current portfolio includes LetibotulinumtoxinA (Letybo) and exclusive distribution of market-leading dermal fillers manufactured by Croma Pharma GmbH. At Hugel Aesthetics, we believe everyone has the right to own their beauty journey; it should be accessible and attainable, leaving you happy and confident.